Skip to main content
    X

    XWELL Inc. (XWEL)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $0.53
    -0.03 (-5.42%)

    Market Cap: $5.62M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    XWELL Inc. (XWEL) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    XWELL (XWEL) trades at 0.2x sales. Its P/S of 0.2x is in line with its 5-year median. Its forward P/E is 10.8x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E10.8x
    Price to sales0.2x
    EV/FCF0.5x
    PEGN/A
    FCF yield-300.3%
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/S0.2x0.2xN/A
    Medians of month-end values through Oct 2026: 58 months (5-year).

    Valuation History

    Over the 5 of the 8 year ends shown that have a P/S, its P/S ranged from 0.1x in 2018 to 2.9x in 2021.

    Year endPriceP/SP/B
    2025$0.46N/AN/A
    2024$1.510.2xN/A
    2023$1.740.2x0.6x
    2022$7.260.6x0.8x
    2021$40.402.9x2.3x
    2020$23.80N/A28.8x
    2019$40.20N/A6.4x
    2018$187.220.1x0.4x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    Frequently Asked Questions About XWEL

    What is XWEL's forward P/E ratio?

    XWELL has a forward P/E ratio of 10.8x.

    What is XWEL's price to sales ratio?

    XWELL has a price to sales ratio of 0.2x.